In FDA-regulated industries, it is imperative that firms be well aware of and understand what policy changes have occurred that will impact them in 2018. In particular, it is critical to learn what policy changes have been implemented for the FDA inspection operation already in force since October 2017. Recent policy changes are widely applicable to FDA-regulated medical products, such as food, drugs, biologics, cosmetics and medical devices including in vitro diagnostics.
Join this session, where regulatory and compliance expert Dr. David Lim, Ph.D., RAC, ASQ-CQA, will discuss the recent changes in FDA policy and the FDA inspection/enforcement operation for 2018. This session will help you better prepare for and manage an FDA-inspection in a proactive and effective manner. David will share his actionable tips and advice in view of recent FDA policy changes.
David will cover the changes to FDA’s new policy and inspection operation practices in 2018. He will discuss how to prepare for a sustainable FDA inspection and will help you be prepared for FDA enforcement and inspection. You will learn the dos and don’ts of the before, during and after aspects on managing the FDA inspection process. With this session, you will improve your awareness and knowledge of FDA enforcement and inspection practices in 2018. David will also share the dos and don’ts of his PASS-IT recommendation and suggestions.
Who Should Attend
Ask a question at the Q&A session following the live event and get advice unique to your situation, directly from our expert speaker.
Dr. David Lim, Ph.D., RAC, ASQ-CQA. Dr. Lim is President and Principal of Regulatory Consulting Firm, Regulatory Doctor (www.RegulatoryDoctor.us). As a leading industry speaker, Dr. Lim frequently presents various topics in areas of FDA regulatory, clinical, quality and regulatory compliance matters in various forums and meetings.